Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Rapanone
Cat. No.:
0225LY-0710
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Rapanone is a naturally occurring benzoquinone that serves as a selective and powerful inhibitor of human synovial PLA2.
Synonym:
2,5-Dihydroxy-3-tridecyl-[1,4]benzoquinone; 2,5-Dihydroxy-3-tridecylcyclohexa-2,5-diene-1,4-dione; 573-40-0; Rapanone; 2,5-Dihydroxy-3-tridecylcyclohexa-2,5-diene-1,4-dione; 2,5-Cyclohexadiene-1,4-dione, 2,5-dihydroxy-3-tridecyl-
CAS No.:
573-40-0
Compound CID:
100659
Formula:
C19H30O4
Formula Weight:
322.44
Specification
Targets&IC50:
PLA2: 2.6 μM
Relative Density:
1.099 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Rapanone can be used in microbiological research to explore its potent antimicrobial activity and potential as a natural defense agent.
Library Information
Target:
Phospholipase
Receptor:
PLA2
Pathways:
Metabolism; Apoptosis; Microbiology/Virology
Plate Number:
AOCL-10
Plate Location:
b7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
65 mg/mL; 201.59 mM
